Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00359892
Status:
COMPLETED
Last Update Posted:
2012-08-06
First Post:
2006-08-02
Brief Title:
Safety and Efficacy of Obatoclax Mesylate GX15-070MS in the Treatment of Hodgkins Lymphoma
Sponsor:
Organization:
Teva Branded Pharmaceutical Products RD Inc